---
truth_dimension: planned
authority_level: advisory
mutation_path: roadmap_update
---

# Phases

This document is the active expanded planning catalog.

- Compact planned phase index: `docs/roadmap/phase-map.md`
- Ordering rationale: `docs/roadmap/sequencing.md`
- Historical truth: `CHANGELOG.md`

## Current planning block: Phases 121-130

## Prior planning blocks

### Phase 85 - Roadmap and Changelog Alignment Check
Goal: reconcile Phase 81-84 outcomes and planning/history posture before outward-facing surfaces.
Boundary: alignment only; no readiness approval.

### Phase 86 - User-Facing Local Workflow Documentation
Goal: document supported local workflows, commands, failure states, non-authority limits, and operator expectations.
Boundary: documentation only; no runtime capability change.

### Phase 87 - Read-Only Observability Snapshot Boundary
Goal: define typed, local, read-only observability snapshots for diagnostics, recovery, append, replay, and action decision status.
Boundary: snapshot is read-only and non-authoritative; no export files, no transport, no persistence.

### Phase 88 - Audit Export Encoding Boundary
Goal: define deterministic export encoding for audit/replay/append/recovery evidence.
Boundary: encoding only; no filesystem export, no network export, no authority mutation.

### Phase 89 - Local Export Write Boundary
Goal: write verified export bundles through the existing persistence boundary.
Boundary: export write is not ledger append, not recovery, not promotion, and not live telemetry.

### Phase 90 - Roadmap and Production Candidate Gap Audit
Goal: reconcile Phases 85-89 and determine whether the next block can pursue startup/package usability.
Boundary: gap audit only; not approval.

### Phase 91 - Transport Abuse and Submission Spoofing Hardening
Goal: add negative-path tests for UI/Rust transport contracts, submission-shaped requests, spoofed operators, and disabled execution flags.
Boundary: hardening only; no live transport.

### Phase 92 - Authorization/Audit/Action Mismatch Hardening
Goal: add negative-path tests for authorization/audit/action proof mismatch, stale proof reuse, identity mismatch, and action-kind escalation.
Boundary: hardening only; no new action authority.

### Phase 93 - Persistence Corruption and Append Drift Hardening
Goal: add negative-path tests for corrupted append envelopes, stale revisions, partial writes, replay drift, and recovery candidate mismatch.
Boundary: hardening only; no new persistence authority.

### Phase 94 - Provider Output Injection and Replay Abuse Hardening
Goal: add negative-path tests for provider-output injection, replay tampering, failure trace spoofing, and retry escalation attempts.
Boundary: hardening only; provider output remains untrusted.

### Phase 95 - Roadmap and Changelog Alignment Check
Goal: reconcile Phase 91-94 hardening outcomes and decide whether local startup/package work is safe.
Boundary: alignment only; no readiness approval.

### Phase 96 - Local Startup Command Boundary
Goal: define the minimal local startup command surface for operator testing.
Boundary: startup command does not imply production service, daemon, network, or public usability.

### Phase 97 - Packaging Artifact Definition
Goal: define what local artifacts are built, named, versioned, and excluded.
Boundary: packaging definition only; no distribution/release approval.

### Phase 98 - Operator Documentation and Troubleshooting Guide
Goal: document startup, validation, expected outputs, failure modes, and rollback expectations for local operators.
Boundary: documentation only; no runtime capability.

### Phase 99 - Release Engineering Dry Run
Goal: validate release checklist mechanics, artifact inventory, changelog/version consistency, and CI gate completeness without publishing.
Boundary: dry run only; no release, no production-candidate approval.

### Phase 100 - Production Candidate Readiness Decision Gate
Goal: determine whether evidence supports a production-candidate branch/tag or whether another hardening block is required.
Boundary: decision gate only; approval only if evidence is complete.

## Planning notes for this block

- This catalog is planned truth and does not duplicate completion claims from `CHANGELOG.md`.
- Roadmap remains planned truth.
- `CHANGELOG.md` remains historical truth.
- This expansion reduces composition density before outward-facing surfaces.
- Production Candidate status remains not approved unless a future decision gate explicitly approves it with complete evidence.
## Post-Phase-100 planned production human-use expansion: Phases 101-120

Phase 99.5 is planning and alignment only. It adds no runtime behavior, adds no new capability, does not approve production human use, does not approve Production Candidate status, does not approve release-candidate readiness, does not approve public usability, does not start Phase 100, and does not implement Phases 101-120.

Phase 110 is the immediate alignment gate for roadmap/changelog drift after Phase 109. Phase 110 does not equal persistence activation, readiness approval, Production Candidate approval, release-candidate approval, public-use approval, or production approval. Phase 111 preserves completed narrow Rust-validated decision-evidence append activation in historical truth. Phase 112 is Recovery Lifecycle Hardening. Phase 112.5 corrects planned-truth drift only; it adds no runtime behavior, adds no new capability, does not implement Phase 113, and does not approve readiness. Phase 113 may begin only as Deployment Configuration Contract work, must not add deployment automation, and must account for Phase 112 recovery handoff gaps. Phases 101-120 are planned truth only and do not imply implementation, readiness, public usability, release-candidate status, Production Candidate status, or production approval.

Production human use is staged in this ladder:

1. Local operator testing
2. Controlled human trial
3. Early human-use candidate
4. Release candidate
5. Production candidate
6. Public/general use

The post-100 roadmap separates UI activation, live local transport, provider execution, alignment/decision checkpoints, narrow persistence activation, deployment, security, human trial, release-candidate evidence, production-candidate reassessment, and controlled human-use gate work.

### Phase 101 - Production Use Gap Decomposition
Goal: Decompose remaining blockers for human use.
Boundary: audit/planning only.
Non-goals: no source changes, no runtime behavior, no UI activation, no transport, no provider execution, no persistence authority, and no readiness approval.
Evidence gate: blocker inventory reconciled against Phase 100 findings without claiming human-use readiness.

### Phase 102 - Human Operator Workflow Contract
Goal: Define operator workflows, roles, and expected states.
Boundary: documentation/contract only.
Non-goals: no workflow automation, no authority mutation, no public usability approval, and no Production Candidate approval.
Evidence gate: operator workflow states are documented as contracts before usability surfaces are activated.

### Phase 103 - UI Runtime Review Surface Activation Boundary
Goal: Activate the browser review surface for human operator visibility.
Boundary: UI usability only; no Rust authority and no live mutation.
Non-goals: no live transport, no provider execution, no persistence authority, no action authority, and no production human-use approval.
Evidence gate: UI activation remains visible/review-only and cannot mutate Rust-owned authority.

### Phase 104 - UI-to-Rust Local Transport Prototype Boundary
Goal: Prototype local UI-to-Rust communication under non-authoritative constraints.
Boundary: local transport prototype only; no provider execution and no persistence authority.
Non-goals: no broad capability, no public transport, no provider/model authority, no persistence authority, and no readiness approval.
Evidence gate: prototype evidence shows the transport remains local and non-authoritative before hardening begins.

### Phase 105 - Transport Abuse Hardening for Live Local Bridge
Goal: Harden the live local bridge against malformed, spoofed, replayed, or hostile transport input.
Boundary: hardening only; no broad capability.
Non-goals: no new operator capability, no provider execution, no persistence authority, and no release-candidate readiness.
Evidence gate: negative-path evidence covers malformed, spoofed, replayed, and hostile input without expanding authority.

### Phase 106 - Provider Configuration Contract
Goal: Reconcile the completed provider configuration contract outcome into planned truth.
Boundary: configuration contract only; no live provider execution.
Non-goals: no provider calls, no model calls, no network execution, no secret activation, and no production approval.
Evidence gate: historical truth records provider configuration contracts as validated intent/configuration only.

### Phase 107 - Provider Execution Sandbox Boundary
Goal: Reconcile the completed bounded deterministic local stub provider execution outcome into planned truth.
Boundary: bounded deterministic local stub execution only; provider output remains untrusted.
Non-goals: no provider authority, no model-output authority, no persistence promotion, no action execution, and no Production Candidate approval.
Evidence gate: historical truth records bounded execution and untrusted-output handling.

### Phase 108 - Provider Timeout and Resource Limit Boundary
Goal: Reconcile the completed deterministic timeout/resource enforcement outcome into planned truth.
Boundary: provider hardening only with descriptive-only evidence; no promotion authority.
Non-goals: no promotion of provider output, no persistence authority, no recovery acceptance, and no release approval.
Evidence gate: historical truth records deterministic timeout/resource enforcement before provider-adjacent authority decisions proceed.

### Phase 109 - Durable Persistence Authority Decision Gate
Goal: Reconcile the completed durable persistence authority decision evidence into planned truth.
Boundary: decision/audit only.
Non-goals: no persistence activation, no durable append expansion, no silent migration, no recovery promotion, and no readiness approval.
Evidence gate: decision evidence permits only a later narrow Rust-validated decision-evidence append candidate and blocks broad persistence categories.

### Phase 110 - Roadmap and Changelog Alignment Check
Goal: Reconcile Phase 106-109 actual outcomes into planned truth, correct stale current-block/immediate-gate language, annotate the archived changelog ordering anomaly outside historical entries, and confirm whether Phase 109 constraints remain valid for a later narrow activation phase.
Boundary: alignment/check only; no runtime behavior, no new capability, no persistence authority, and no Phase 111 implementation.
Non-goals: no durable append activation, no provider-output authority, no replay repair, no recovery promotion, no action execution, no readiness approval, no Production Candidate approval, no release-candidate approval, no public-use approval, and no production-human-use approval.
Evidence gate: alignment evidence confirms roadmap remains planned truth, changelog surfaces remain historical truth, historical entries were not rewritten, and Phase 111 may begin only if Phase 109/110 constraints remain valid.

### Phase 111 - Narrow Persistence Activation Boundary
Goal: Preserve completed narrow Rust-validated decision-evidence append activation under Phase 109/110 constraints in planned-truth sequencing.
Boundary: narrow decision-evidence append only; not broad persistence authority.
Non-goals: no provider-output authority, no provider trust, no workflow-completion authority, no UI-authorized persistence, no transport-authorized persistence, no replay repair, no recovery promotion, no action execution, no readiness approval, no Production Candidate approval, no release-candidate approval, no public-use approval, and no production-human-use approval.
Evidence gate: historical truth records narrow Rust-validated decision-evidence append activation mapped to Phase 109 reason codes and Phase 110 alignment findings.

### Phase 112 - Recovery Lifecycle Hardening
Goal: Preserve completed recovery lifecycle hardening for Phase 111 decision-evidence records in planned-truth sequencing.
Boundary: recovery lifecycle hardening only.
Non-goals: no replay repair, no recovery promotion, no action execution, no provider trust, no provider output promotion, no broad persistence authority, no readiness approval, no Production Candidate approval, no release-candidate approval, no public-use approval, no production-human-use approval, and no Phase 113 implementation.
Evidence gate: historical truth records fail-closed recovery classification and prohibited recovery authority coverage.

### Phase 113 - Deployment Configuration Contract
Goal: Define deployment configuration contracts without deployment automation while accounting for Phase 112 recovery handoff gaps.
Boundary: deployment config only; no deployment automation.
Non-goals: no deployment automation, no installer, no distribution, no publishing, no startup/package readiness approval, no background repair, no automatic replay patching, no continue-anyway recovery behavior, no migration/version upgrade authority, no production recovery guarantee, and no release evidence guarantee.
Evidence gate: deployment configuration is documented as contract evidence only and covers storage paths, permissions, retention, environment assumptions, failure handling, and manual review for corrupt or unsupported recovery evidence.

### Phase 114 - Policy Versioning and Governance Evidence Boundary
Goal: Add policy versioning and governance evidence traceability as planned future work.
Boundary: policy/governance versioning only; not completed Phase 112 work.
Non-goals: no governance rule rewrite, no architecture authority change, no source authority expansion, no deployment automation, and no release-candidate approval.
Evidence gate: policy version evidence is traceable and does not change runtime authority by itself.

### Phase 115 - Security Threat Model and Abuse-Case Audit
Goal: Audit threat model, abuse cases, trust boundaries, and residual attack surfaces.
Boundary: security audit only.
Non-goals: no runtime repair, no new security tooling, no authority expansion, and no readiness approval.
Evidence gate: threat model and abuse-case findings are recorded before human-trial documentation proceeds.

### Phase 116 - Local Deployment Candidate Boundary
Goal: Define a local deployment candidate boundary for controlled testing after deployment configuration and security audit evidence.
Boundary: local deployment candidate only; no public release.
Non-goals: no public release, no distribution approval, no installer approval, no production approval, and no public/general use.
Evidence gate: local deployment candidate evidence remains controlled and non-public.

### Phase 117 - Operator Documentation and Human Trial Dry Run
Goal: Prepare and rehearse controlled human-trial procedures without public availability.
Boundary: operator docs and dry run only; no readiness approval and no public availability.
Non-goals: no public/general use, no production human-use approval, no release-candidate approval, and no Production Candidate approval.
Evidence gate: documentation and dry-run evidence show procedures can be rehearsed without making the system publicly available.

### Phase 118 - Release Candidate Evidence Assembly
Goal: Assemble release-candidate evidence without approval.
Boundary: evidence assembly only; no automatic approval.
Non-goals: no Release Candidate approval, no release-candidate readiness claim, no production approval, and no public usability approval.
Evidence gate: release-candidate evidence is assembled for review and remains non-approving.

### Phase 119 - Production Candidate Reassessment
Goal: Reassess Production Candidate posture after controlled evidence assembly.
Boundary: decision gate only.
Non-goals: no automatic approval, no public release, no general-use approval, and no bypass of evidence gates.
Evidence gate: reassessment records whether the posture remains blocked or can proceed under explicit evidence constraints.

### Phase 120 - Early Human-Use Candidate Gate
Goal: Decide whether controlled early human use is permitted.
Boundary: current planned gate for controlled human use; not a guaranteed final endpoint and not general public release.
Non-goals: no public/general use, no automatic production approval, no release-candidate shortcut, no guaranteed final endpoint, and no broad availability.
Evidence gate: controlled early human-use permission, if granted by future evidence, remains separate from public/general use and may shift if intervening evidence requires it.


## Current planning block detail: Phases 121-130

Roadmap remains planned truth. CHANGELOG surfaces remain historical truth. Phase 120 is complete as Early Human-Use Candidate Gate only; it permitted `early_human_use_candidate_permitted_with_constraints` under bounded, non-public, local/trial-only, manually reviewed constraints for named internal/trial participants. Phase 120 is not a guaranteed final endpoint, not Release Candidate approval, not Production Candidate approval, not public/general use, not production readiness, not production deployment, and not production human use.

Phase 121 is roadmap expansion and production gap reassessment only. Phase 121 adds no runtime behavior, no new capability, no Rust source changes, no TypeScript source changes, no test changes, no schema changes, no provider execution expansion, no persistence authority expansion, no recovery promotion, no replay repair, no action execution, no installer/update/signing/publishing behavior, no deployment automation, no release artifacts, no packages, no GitHub release, no release tag, no public download, no public asset, and no readiness approval.

The production-human-use ladder remains: Local operator testing; Controlled human trial; Early human-use candidate; Release candidate; Production candidate; Public/general use. Public/general use remains the final rung. Later phases may extend beyond Phase 130 if evidence requires it.

### Phase 121 - Post-120 Roadmap Expansion and Production Gap Reassessment
Goal: Expand the roadmap beyond Phase 120 based on Phase 118-120 evidence and remaining usability, deployment, observability, release, and public-use gaps.
Boundary: audit/planning only; no implementation, readiness approval, public usability approval, Release Candidate approval, Production Candidate approval, production approval, deployment automation, or public/general use.
Non-goals: no runtime behavior, no new capability, no early-human-use authority expansion, no release artifacts, no packages, no installer behavior, no update-channel behavior, no signing/publishing behavior, no GitHub release/tag/public download asset, no production deployment, no provider trust, no provider output promotion, no replay repair, no recovery promotion, and no action execution.
Evidence gate: committed evidence only; prompt intent, uncommitted work, speculative roadmap claims, validation success, Phase 118 evidence assembly, Phase 119 reassessment, and Phase 120 constrained early-human-use candidacy do not approve later rungs.

### Phase 122 - Controlled Early Human-Use Trial Boundary
Goal: Conduct or rehearse bounded early human-use under Phase 120 constraints and manual review.
Boundary: controlled early-human-use trial only; no public release.
Non-goals: no public/general use, no production human use, no Release Candidate status, no Production Candidate status, no production deployment, no readiness approval, and no expansion beyond named internal/trial participants unless a later phase explicitly grants it.
Evidence gate: trial evidence must remain bounded, manually reviewed, stopped on boundary drift, and separated from release, production, and public-use evidence.

### Phase 123 - Early Human-Use Evidence Review and Operator Feedback Audit
Goal: Review early human-use evidence, operator notes, stop conditions, usability findings, and unresolved safety issues.
Boundary: audit/evidence review only.
Non-goals: no readiness approval, no implicit promotion, no trust inference from provider output or human feedback, and no public/general-use approval.
Evidence gate: findings identify confirmed vs suspected issues and cannot collapse evidence categories.

### Phase 124 - Operational Usability Remediation Boundary
Goal: Address confirmed usability blockers for local operators and bounded early human-use participants.
Boundary: usability remediation only; no readiness approval.
Non-goals: no release approval, no Production Candidate approval, no public usability approval, no production deployment, and no provider/persistence/recovery/action authority expansion.
Evidence gate: remediation evidence must be specific to operator ergonomics, UI usability, transport usability, supportability, or documentation; it does not approve later ladder rungs.

### Phase 125 - Roadmap, Changelog, and Production-Path Reassessment
Goal: Reconcile Phase 121-124 outcomes and reassess whether Phase 126-130 should be preserved, preserved with caveats, remapped, deferred, or expanded beyond Phase 130.
Boundary: alignment/checkpoint only; no readiness approval.
Non-goals: no Release Candidate approval, no Production Candidate approval, no public/general-use approval, no production human-use approval, no release artifact creation, and no public release.
Evidence gate: preserves the 0/5 checkpoint cadence; Phase 119 remains an intentional decision-gate exception and does not redefine the 0/5 convention.

### Phase 126 - Release Packaging Contract
Goal: Define packaging, artifact, checksum, provenance, distribution, and non-public/public-boundary contracts.
Boundary: release packaging contract only; no release artifact publication.
Non-goals: no package creation, no GitHub release, no release tag, no public download, no public asset, no signing activation, no publishing activation, no installer/update-channel activation, and no release-candidate readiness approval.
Evidence gate: contracts identify artifact provenance, checksum/signing expectations, distribution governance, and public-boundary prohibitions without creating artifacts.

### Phase 127 - Installer and Update-Channel Threat Boundary
Goal: Define installer/update-channel risks, constraints, prohibited behaviors, and future evidence requirements.
Boundary: threat model/contract only; no installer or update-channel activation.
Non-goals: no installer behavior, no update-channel behavior, no signing/publishing behavior, no background service, no daemon behavior, no production deployment automation, and no public release.
Evidence gate: threat evidence covers public download governance, update trust, rollback risks, and prohibited activation paths.

### Phase 128 - Observability and Operational Evidence Boundary
Goal: Define operational telemetry, audit, failure reporting, incident evidence, and operator evidence-capture requirements.
Boundary: observability evidence only; no production monitoring claim.
Non-goals: no production readiness, no incident-response approval, no production deployment, no background telemetry service, no network telemetry activation, and no public-use approval.
Evidence gate: observability, operational evidence, operational telemetry, incident response, rollback, recovery procedures, support model, and deployment environment assumptions are recorded as evidence requirements only.

### Phase 129 - Release Candidate Dry Run
Goal: Rehearse release-candidate assembly without publishing or approving release-candidate readiness.
Boundary: dry run only; no release approval.
Non-goals: no release artifacts, no packages, no public downloads, no signatures/publications, no Release Candidate approval, no Production Candidate approval, no production deployment, and no public/general use.
Evidence gate: dry runs are not release; dry-run evidence cannot approve readiness.

### Phase 130 - Release Candidate Decision Gate
Goal: Decide whether evidence supports Release Candidate status or requires another hardening block.
Boundary: decision gate only.
Non-goals: no Production Candidate status, no production readiness, no production deployment, no production human use, no public usability approval, and no public/general use.
Evidence gate: Release Candidate evidence must be fresh and phase-scoped; approval, if any, applies only to Release Candidate status and cannot imply Production Candidate status or public/general use.

## Post-130 planned evidence block

Phase 130 is complete with decision status `rc_candidate_not_ready`. Phase 130 did not approve Release Candidate status, Production Candidate status, public/general use, or production-human-use approval, and Phase 130 did not create the missing evidence it identified. Phase 131 must not be a rerun of Phase 130 without new evidence.


### Phase 131 - Post-130 Roadmap Expansion and Release Evidence Remap
Goal: Convert Phase 130's `rc_candidate_not_ready` findings into the next evidence-producing block.
Boundary: audit/planning only.
Non-goals: no Phase 132+ implementation, no Release Candidate approval, no Production Candidate approval, no public/general use, and no rerun of Phase 130 without new evidence.
Evidence gate: Phase 131 must map the categories that blocked Release Candidate supportability to production or explicit deferral in later phases.

### Phase 132 - Release Artifact Creation Boundary
Goal: Create controlled release artifact outputs under the Phase 126 contract.
Boundary: local/non-public artifact creation only; no publishing.
Non-goals: no public asset, GitHub release, release tag, public download, signing, publishing, deployment, or readiness approval.
Evidence gate: artifact outputs must remain controlled and non-public.

### Phase 133 - Checksum and Provenance Evidence Boundary
Goal: Generate and validate checksum/provenance evidence for controlled artifacts.
Boundary: checksum/provenance evidence only; no signing or publishing.
Non-goals: no publication, public download, release approval, or public/general-use approval.
Evidence gate: checksum and provenance evidence cannot imply release, deployment, or readiness.

### Phase 134 - Signing and Key-Custody Implementation Boundary
Goal: Introduce signing/key-custody controls or explicitly defer them.
Boundary: signing/key-custody implementation only if evidence permits; no publishing.
Non-goals: no public signatures, public assets, publication, public download, or automatic Release Candidate approval.
Evidence gate: key custody and signing controls must be scoped, non-public, and separately justified or explicitly deferred.

### Phase 135 - Roadmap and Changelog Alignment Check
Goal: Reconcile Phase 131-134 and decide whether installer/update-channel or release dry-run work may proceed.
Boundary: alignment only; no readiness approval.
Non-goals: no installer/update-channel implementation, no release approval, no Production Candidate approval, and no public/general use.
Evidence gate: reconciliation can authorize later scoped work only as planned truth.

### Phase 135.1 - Artifact Chain Correction Before Installer/Update-Channel Work
Goal: Resolve or explicitly defer the blocked artifact chain before Phase 136 implementation proceeds.
Boundary: artifact-chain correction boundary only; no signing, publishing, installer/update-channel activation, deployment, monitoring, or readiness approval.
Non-goals: no Phase 136 implementation, no signing behavior, no publishing behavior, no deployment behavior, no monitoring activation, no Release Candidate approval, no Production Candidate approval, and no public/general use.
Evidence gate: determine whether Phase 132 artifact creation can be rerun under the Phase 132.1 contract, create or defer governed local/non-public artifacts, produce or defer artifact manifest evidence, and determine whether Phase 133 checksum/provenance can proceed afterward.

### Phase 136 - Installer/Update-Channel Implementation Boundary
Goal: Implement or further defer installer/update-channel surfaces under Phase 127 constraints after Phase 135.1 resolves or explicitly defers the artifact-chain dependency.
Boundary: controlled implementation only; no public distribution; deferred until Phase 135.1 resolves or explicitly defers the artifact-chain dependency.
Non-goals: no public update service, public installer distribution, publishing, deployment automation, background service, or readiness approval.
Evidence gate: installer/update-channel evidence must remain constrained or be explicitly deferred.

### Phase 137 - Operational Observability Implementation Boundary
Goal: Implement local/non-production observability evidence capture if permitted.
Boundary: controlled observability implementation only; no production monitoring claim.
Non-goals: no production monitoring, production telemetry endpoint, alerting, dashboarding, public service, deployment, or readiness approval.
Evidence gate: observability evidence capture is not monitoring supportability and cannot imply production operations.

### Phase 138 - Incident, Support, and Rollback Evidence Boundary
Goal: Define and test incident, support, rollback, and recovery evidence.
Boundary: operational procedure/evidence only; no production support claim.
Non-goals: no production support operations, deployment automation, recovery promotion, replay repair, public support commitment, or readiness approval.
Evidence gate: procedure evidence must stay separate from support, deployment, and recovery authority.

### Phase 139 - Release Candidate Evidence Reassembly
Goal: Reassemble Release Candidate evidence after artifact, provenance, signing, installer/update, and observability work.
Boundary: evidence assembly only; no approval.
Non-goals: no Release Candidate approval, Production Candidate approval, public/general use, release, deployment, or publication.
Evidence gate: evidence reassembly cannot substitute for the Phase 140 decision gate.

### Phase 140 - Release Candidate Re-Decision Gate
Goal: Decide whether Release Candidate status is now supportable or whether another hardening block is required.
Boundary: decision gate only.
Non-goals: no automatic Release Candidate approval, no Production Candidate approval, no production readiness, no production deployment, no production human use, and no public/general use.
Evidence gate: Phase 140 may approve only if category-specific committed evidence supports it; otherwise another hardening block is required.

## Post-140 dependency note

Do not map Production Candidate or public/general-use as automatically following Phase 140. Any post-140 block depends on the Phase 140 decision and must preserve the ladder: Local operator testing → Controlled human trial → Early human-use candidate → Release candidate → Production candidate → Public/general use.

Public/general use remains the later final rung. Phase 131-140 are sufficient for the next detailed roadmap block after Phase 130, but they are not sufficient to complete the ladder.
